N-methylnicotinamide protects against endothelial dysfunction and attenuates atherogenesis in apolipoprotein E-deficient mice

Molecular Nutrition & Food Research
Nan JiangMin Xia

Abstract

Epidemiological studies have demonstrated that N-methylnicotinamide (MNA) may exert antithrombotic and anti-inflammatory effects on the endothelium. However, the exact role of MNA in endothelial function remains uncertain. Apolipoprotein E-deficient (apoE(-/-) ) mice fed with a high-fat, high-cholesterol diet (HCD) and human umbilical vein endothelial cells (HUVECs) were used to explore the role of MNA in endothelial function and its underlying mechanism. The endothelium-dependent vasorelaxation to acetylcholine in the aortas of low and high dose MNA-fed apoE(-/-) mice was improved by 24 and 36% (p < 0.05), respectively, compared with high-fat, HCD-fed control. MNA significantly increased nitric oxide/cyclic guanosinemonophosphate levels and decreased asymmetric dimethylarginine (ADMA) concentrations by induction of dimethylarginine dimethylaminohydrolase (DDAH)2 both in aorta and endothelial cells. Neither the activity nor the protein expression of DDAH1 was influenced upon MNA treatment. Then, DDAH2 depletion by RNA interference in HUVECs abolished the protective effect of MNA on endothelial function. Mechanically, this could be attributed to a direct modulation of the methylation level of DDAH2 gene promoter region by MNA. T...Continue Reading

References

Nov 14, 2000·Circulation Research·H Cai, D G Harrison
Aug 17, 2001·Current Opinion in Lipidology·S KinlayP Ganz
Jan 6, 2004·Cellular and Molecular Life Sciences : CMLS·G MagniS Ruggieri
Apr 24, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Patrick Vallance, James Leiper
Jun 9, 2004·Free Radical Biology & Medicine·Gökce TopalMonique David-Dufilho
Jun 17, 2004·Circulation·Jean Davignon, Peter Ganz
Apr 14, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Soni PullamsettiRalph Theo Schermuly
Feb 3, 2007·Nature Medicine·James LeiperPatrick Vallance
Mar 1, 2007·Journal of Cell Science·Beata Wojciak-StothardPatrick Vallance
Feb 23, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Tora LeongUNKNOWN Swedish-Irish-Norwegian Collaboration
Apr 4, 2008·The Journal of Pharmacology and Experimental Therapeutics·Tomasz BrzozowskiWieslaw W Pawlik
Aug 22, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kumiko FurukiTsutomu Imaizumi
Sep 17, 2009·Current Pharmaceutical Design·Huige Li, Ulrich Förstermann
Sep 6, 2011·European Heart Journal·Ulrich Förstermann, William C Sessa
Jun 7, 2013·Molecular Nutrition & Food Research·Julie LorinLuc Rochette

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.